Tralokinumab in the treatment of resistant atopic dermatitis: An open-label, retrospective case series study

J Eur Acad Dermatol Venereol. 2023 May;37(5):e644-e645. doi: 10.1111/jdv.18753. Epub 2022 Nov 26.

Authors

Elena Pezzolo^{1

2}, Luigi Naldi^{1

2}

Affiliations

¹ Department of Dermatology, San Bortolo Hospital, Vicenza, Italy.
² A Study Centre of the Italian Group for the Epidemiologic Research in Dermatology (GISED), Bergamo, Italy.

PMID: 36404138
DOI: 10.1111/jdv.18753

No abstract available

Publication types

Clinical Trial
Letter

MeSH terms

Antibodies, Monoclonal / therapeutic use
Dermatitis, Atopic* / drug therapy
Humans
Retrospective Studies
Treatment Outcome

Substances

Antibodies, Monoclonal
tralokinumab